PSEN1 and Alzheimer disease: Consistent with the results of the present study, Chaney et al. (2021) found reduced NAA content in the hippocampus of APP/PS1 transgenic AD model mice, and similarly, Fowler et al. (2022) found reduced NAA/mI in the hippocampus of APP/PS1 transgenic AD model mice.